Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11438]

Pancreatic cancer spreads to liver or lung thanks to this protein

Pancreatic cancer spreads to liver or lung thanks to this protein

ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study...

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

Loss of Y chromosome leads to poor cancer outcomes

Loss of Y chromosome leads to poor cancer outcomes

Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts

Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts

ASCO 2025: Artificial intelligence assistance can help improve accuracy in identifying HER2-low and HER2-ultralow breast cancers, avoid misclassification

ASCO 2025: Artificial intelligence assistance can help improve accuracy in identifying HER2-low and HER2-ultralow...

ASCO 2025: GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for people with diabetes

ASCO 2025: GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for people with...

ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer

ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients...

ASCO 2025: Study highlights potential new treatment for aggressive form of acute myeloid leukaemia

ASCO 2025: Study highlights potential new treatment for aggressive form of acute myeloid leukaemia

New biomarker may guide best use of KRAS inhibitors in lung cancer

New biomarker may guide best use of KRAS inhibitors in lung cancer

More from ecancer